413 related articles for article (PubMed ID: 38588450)
1. Home versus in-centre haemodialysis for people with kidney failure.
Cheetham MS; Ethier I; Krishnasamy R; Cho Y; Palmer SC; Johnson DW; Craig JC; Stroumza P; Frantzen L; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2024 Apr; 4(4):CD009535. PubMed ID: 38588450
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Psychosocial interventions for preventing and treating depression in dialysis patients.
Natale P; Palmer SC; Ruospo M; Saglimbene VM; Rabindranath KS; Strippoli GF
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004542. PubMed ID: 31789430
[TBL] [Abstract][Full Text] [Related]
4. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
Ruospo M; Palmer SC; Natale P; Craig JC; Vecchio M; Elder GJ; Strippoli GF
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006023. PubMed ID: 30132304
[TBL] [Abstract][Full Text] [Related]
5. Interventions for fatigue in people with kidney failure requiring dialysis.
Natale P; Ju A; Strippoli GF; Craig JC; Saglimbene VM; Unruh ML; Stallone G; Jaure A
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD013074. PubMed ID: 37651553
[TBL] [Abstract][Full Text] [Related]
6. Potassium binders for chronic hyperkalaemia in people with chronic kidney disease.
Natale P; Palmer SC; Ruospo M; Saglimbene VM; Strippoli GF
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013165. PubMed ID: 32588430
[TBL] [Abstract][Full Text] [Related]
7. Interventions for improving sleep quality in people with chronic kidney disease.
Natale P; Ruospo M; Saglimbene VM; Palmer SC; Strippoli GF
Cochrane Database Syst Rev; 2019 May; 5(5):CD012625. PubMed ID: 31129916
[TBL] [Abstract][Full Text] [Related]
8. Calcium channel blockers for people with chronic kidney disease requiring dialysis.
Mugendi GA; Mutua FM; Natale P; Esterhuizen TM; Strippoli GF
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD011064. PubMed ID: 33000470
[TBL] [Abstract][Full Text] [Related]
9. Interventions for weight loss in people with chronic kidney disease who are overweight or obese.
Conley MM; McFarlane CM; Johnson DW; Kelly JT; Campbell KL; MacLaughlin HL
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013119. PubMed ID: 33782940
[TBL] [Abstract][Full Text] [Related]
10. Low protein diets for non-diabetic adults with chronic kidney disease.
Hahn D; Hodson EM; Fouque D
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001892. PubMed ID: 30284724
[TBL] [Abstract][Full Text] [Related]
11. Low protein diets for non-diabetic adults with chronic kidney disease.
Hahn D; Hodson EM; Fouque D
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD001892. PubMed ID: 33118160
[TBL] [Abstract][Full Text] [Related]
12. Urgent-start peritoneal dialysis versus haemodialysis for people with chronic kidney disease.
Htay H; Johnson DW; Craig JC; Teixeira-Pinto A; Hawley CM; Cho Y
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD012899. PubMed ID: 33501650
[TBL] [Abstract][Full Text] [Related]
13. Synbiotics, prebiotics and probiotics for people with chronic kidney disease.
Cooper TE; Khalid R; Chan S; Craig JC; Hawley CM; Howell M; Johnson DW; Jaure A; Teixeira-Pinto A; Wong G
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013631. PubMed ID: 37870148
[TBL] [Abstract][Full Text] [Related]
14. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Tunnicliffe DJ; Palmer SC; Cashmore BA; Saglimbene VM; Krishnasamy R; Lambert K; Johnson DW; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2023 Nov; 11(11):CD007784. PubMed ID: 38018702
[TBL] [Abstract][Full Text] [Related]
15. Non-immunosuppressive treatment for IgA nephropathy.
Tunnicliffe DJ; Reid S; Craig JC; Samuels JA; Molony DA; Strippoli GF
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD003962. PubMed ID: 38299639
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
Cooper TE; Teng C; Tunnicliffe DJ; Cashmore BA; Strippoli GF
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD007751. PubMed ID: 37466151
[TBL] [Abstract][Full Text] [Related]
17. Parenteral versus oral iron therapy for adults and children with chronic kidney disease.
O'Lone EL; Hodson EM; Nistor I; Bolignano D; Webster AC; Craig JC
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD007857. PubMed ID: 30790278
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet agents for chronic kidney disease.
Natale P; Palmer SC; Saglimbene VM; Ruospo M; Razavian M; Craig JC; Jardine MJ; Webster AC; Strippoli GF
Cochrane Database Syst Rev; 2022 Feb; 2(2):CD008834. PubMed ID: 35224730
[TBL] [Abstract][Full Text] [Related]
19. Low dialysate sodium levels for chronic haemodialysis.
Dunlop JL; Vandal AC; Marshall MR
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011204. PubMed ID: 30646428
[TBL] [Abstract][Full Text] [Related]
20. Upper limb exercise for arteriovenous fistula maturation in people requiring permanent haemodialysis access.
Nantakool S; Reanpang T; Prasannarong M; Pongtam S; Rerkasem K
Cochrane Database Syst Rev; 2022 Oct; 10(10):CD013327. PubMed ID: 36184076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
